BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 31318878)

  • 21. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry.
    Hu S; Xie Y; Ramachandran P; Ogorzalek Loo RR; Li Y; Loo JA; Wong DT
    Proteomics; 2005 Apr; 5(6):1714-28. PubMed ID: 15800970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast.
    Streckfus CF; Mayorga-Wark O; Arreola D; Edwards C; Bigler L; Dubinsky WP
    Cancer Invest; 2008 Mar; 26(2):159-67. PubMed ID: 18259946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers.
    Jancsik VA; Gelencser G; Maasz G; Schmidt J; Molnar GA; Wittmann I; Olasz L; Mark L
    Pathol Oncol Res; 2014 Jul; 20(3):591-5. PubMed ID: 24343817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LC-MALDI-TOF/TOF for shotgun proteomics.
    Fernández-Puente P; Mateos J; Blanco FJ; Ruiz-Romero C
    Methods Mol Biol; 2014; 1156():27-38. PubMed ID: 24791979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Multiplexed Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry (LC-MRM/MS) Method for Evaluation of Salivary Proteins as Oral Cancer Biomarkers.
    Chen YT; Chen HW; Wu CF; Chu LJ; Chiang WF; Wu CC; Yu JS; Tsai CH; Liang KH; Chang YS; Wu M; Ou Yang WT
    Mol Cell Proteomics; 2017 May; 16(5):799-811. PubMed ID: 28235782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic bead-based salivary peptidome profiling analysis during orthodontic treatment durations.
    Zhang J; Zhou S; Zheng H; Zhou Y; Chen F; Lin J
    Biochem Biophys Res Commun; 2012 May; 421(4):844-9. PubMed ID: 22554512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of glycation and glycation sites of lysozyme by matrix-assisted laser desorption/ionization time of flight/time-of-flight mass spectrometry and Liquid chromatography-electrospray ionization tandem mass spectrometry.
    Ruan ED; Wang H; Ruan Y; Juáreza M
    Eur J Mass Spectrom (Chichester); 2014; 20(4):327-36. PubMed ID: 25420345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.
    Yu JS; Chen YT; Chiang WF; Hsiao YC; Chu LJ; See LC; Wu CS; Tu HT; Chen HW; Chen CC; Liao WC; Chang YT; Wu CC; Lin CY; Liu SY; Chiou ST; Chia SL; Chang KP; Chien CY; Chang SW; Chang CJ; Young JD; Pao CC; Chang YS; Hartwell LH
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11549-11554. PubMed ID: 27663741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary proteomics for oral cancer biomarker discovery.
    Hu S; Arellano M; Boontheung P; Wang J; Zhou H; Jiang J; Elashoff D; Wei R; Loo JA; Wong DT
    Clin Cancer Res; 2008 Oct; 14(19):6246-52. PubMed ID: 18829504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH; Pan S; Zhang J; Gao J
    Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potential salivary biomarker panels for oral squamous cell carcinoma.
    Jain A; Kotimoole CN; Ghoshal S; Bakshi J; Chatterjee A; Prasad TSK; Pal A
    Sci Rep; 2021 Feb; 11(1):3365. PubMed ID: 33564003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry.
    Benkali K; Marquet P; Rérolle J; Le Meur Y; Gastinel L
    BMC Genomics; 2008 Nov; 9():541. PubMed ID: 19014585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of MALDI Imaging Proteolytic Peptides Using LC-MS/MS-Based Biomarker Discovery Data: A Proof of Concept.
    Longuespée R; Ly A; Casadonte R; Schwamborn K; Kazdal D; Zgorzelski C; Bollwein C; Kriegsmann K; Weichert W; Kriegsmann J; Schirmacher P; Fresnais M; Oliveira C; Kriegsmann M
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800158. PubMed ID: 30525291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles.
    Winck FV; Prado Ribeiro AC; Ramos Domingues R; Ling LY; Riaño-Pachón DM; Rivera C; Brandão TB; Gouvea AF; Santos-Silva AR; Coletta RD; Paes Leme AF
    Sci Rep; 2015 Nov; 5():16305. PubMed ID: 26538482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in saliva of dogs with canine leishmaniosis: A proteomic approach.
    Franco-Martínez L; Tvarijonaviciute A; Horvatić A; Guillemin N; Bernal LJ; Barić Rafaj R; Cerón JJ; Thomas MDC; López MC; Tecles F; Martínez-Subiela S; Mrljak V
    Vet Parasitol; 2019 Aug; 272():44-52. PubMed ID: 31395204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of mammalian cell lines using MALDI-TOF and LC-ESI-MS/MS mass spectrometry.
    Zhang X; Scalf M; Berggren TW; Westphall MS; Smith LM
    J Am Soc Mass Spectrom; 2006 Apr; 17(4):490-499. PubMed ID: 16488154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant proteins in the saliva of patients with oral squamous cell carcinoma.
    Jessie K; Jayapalan JJ; Ong KC; Abdul Rahim ZH; Zain RM; Wong KT; Hashim OH
    Electrophoresis; 2013 Sep; 34(17):2495-502. PubMed ID: 23784731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis.
    Liu Y; Tan YR; Sun WW; Ju WT; Fu Y; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
    Proteomics Clin Appl; 2018 Sep; 12(5):e1700180. PubMed ID: 29461673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.